36.96
price down icon0.73%   -0.27
after-market アフターアワーズ: 36.55 -0.41 -1.11%
loading
前日終値:
$37.23
開ける:
$37.32
24時間の取引高:
1.30M
Relative Volume:
0.73
時価総額:
$4.41B
収益:
$18.47M
当期純損益:
$-589.53M
株価収益率:
-7.0266
EPS:
-5.26
ネットキャッシュフロー:
$-399.80M
1週間 パフォーマンス:
-4.20%
1か月 パフォーマンス:
+13.97%
6か月 パフォーマンス:
-19.34%
1年 パフォーマンス:
-34.48%
1日の値動き範囲:
Value
$36.71
$38.03
1週間の範囲:
Value
$36.71
$39.47
52週間の値動き範囲:
Value
$29.31
$61.38

Cytokinetics Inc Stock (CYTK) Company Profile

Name
名前
Cytokinetics Inc
Name
セクター
Healthcare (1161)
Name
電話
(650) 624-3000
Name
住所
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
職員
498
Name
Twitter
@Cytokinetics
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CYTK's Discussions on Twitter

CYTK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CYTK
Cytokinetics Inc
36.96 4.61B 18.47M -589.53M -399.80M -5.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-24 開始されました Barclays Overweight
2025-02-07 開始されました Citigroup Buy
2025-01-22 開始されました Stifel Buy
2024-11-08 開始されました RBC Capital Mkts Outperform
2024-08-13 ダウングレード Goldman Buy → Neutral
2024-01-24 ダウングレード UBS Buy → Neutral
2024-01-05 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-11-09 開始されました Goldman Buy
2023-11-07 開始されました B. Riley Securities Buy
2023-08-15 開始されました SVB Securities Outperform
2023-02-17 開始されました BofA Securities Neutral
2022-12-23 繰り返されました Needham Buy
2022-12-20 開始されました Truist Buy
2022-10-11 開始されました UBS Buy
2022-01-28 開始されました Goldman Buy
2021-12-22 開始されました Oppenheimer Outperform
2021-12-10 開始されました JP Morgan Overweight
2021-10-07 開始されました Jefferies Buy
2021-03-12 開始されました Wolfe Research Outperform
2021-02-18 開始されました Barclays Overweight
2021-01-20 繰り返されました H.C. Wainwright Buy
2020-10-29 開始されました Goldman Neutral
2020-07-10 開始されました Raymond James Strong Buy
2020-05-05 開始されました Mizuho Buy
2020-04-09 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-09-21 開始されました Cantor Fitzgerald Overweight
2018-09-10 再開されました Morgan Stanley Equal-Weight
2017-11-22 繰り返されました Morgan Stanley Overweight
2017-11-22 ダウングレード Needham Strong Buy → Buy
2017-11-21 繰り返されました H.C. Wainwright Buy
2017-07-31 開始されました Morgan Stanley Overweight
2017-03-08 開始されました Rodman & Renshaw Buy
2017-02-06 アップグレード Needham Buy → Strong Buy
2016-12-16 開始されました Cantor Fitzgerald Overweight
2016-07-28 繰り返されました Needham Buy
2015-11-10 繰り返されました FBR Capital Outperform
2015-11-09 繰り返されました ROTH Capital Buy
2015-07-24 繰り返されました MLV & Co Buy
2014-12-31 繰り返されました ROTH Capital Buy
2014-11-04 アップグレード MLV & Co Hold → Buy
2014-04-28 繰り返されました Needham Buy
すべてを表示

Cytokinetics Inc (CYTK) 最新ニュース

pulisher
12:47 PM

Is Cytokinetics Incorporated a good long term investmentTremendous financial leverage - jammulinksnews.com

12:47 PM
pulisher
Jul 21, 2025

Cytokinetics, Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cytokinetics, Incorporated (CYTK) - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 20, 2025

Cytokinetics Incorporated Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Cytokinetics Incorporated stockHigh-octane financial growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Cytokinetics Incorporated stock priceUnmatched profit potential - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jul 18, 2025
pulisher
Jul 18, 2025

Cytokinetics’ Aficamten Study: A New Hope for Pediatric Heart Patients - TipRanks

Jul 18, 2025
pulisher
Jul 15, 2025

Cytokinetics CEO Makes a Significant Stock Move! - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Cytokinetics (CYTK) CEO Blum sells $190k in stock - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Cytokinetics (CYTK) CEO Blum sells $190k in stock By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Why Cytokinetics Incorporated stock attracts strong analyst attentionFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cytokinetics Incorporated stock price move sharplyDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Cytokinetics, Incorporated (CYTK) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Jul 14, 2025
pulisher
Jul 11, 2025

CYTK ALERTLevi & Korsinsky Has Commenced an Investigation on Behalf of Cytokinetics, Incorporated Shareholders Who Lost Money - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 - The Manila Times

Jul 10, 2025
pulisher
Jul 10, 2025

Cytokinetics to Showcase Positive Aficamten Results for Obstructive Hypertrophic Cardiomyopathy at European Society of Cardiology Congress 2025 - Quiver Quantitative

Jul 10, 2025
pulisher
Jul 09, 2025

Cytokinetics(CYTK) Soars 6.93% on Analyst Optimism - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Cytokinetics, Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsCYTK - ACCESS Newswire

Jul 09, 2025
pulisher
Jul 07, 2025

Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT - MSN

Jul 07, 2025
pulisher
Jul 06, 2025

Cytokinetics (CYTK): Balancing Optimism and Caution in Aficamten's High-Stakes Journey - AInvest

Jul 06, 2025
pulisher
Jul 01, 2025

CYTK ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cytokinetics, Incorporated Shareholders Who Lost Money - ACCESS Newswire

Jul 01, 2025
pulisher
Jun 27, 2025

CYTK ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Cytokinetics, Incorporated - ACCESS Newswire

Jun 27, 2025
pulisher
Jun 25, 2025

Cytokinetics Presents Positive Aficamten Data for Obstructive HCM at European Heart Failure Congress - Yahoo.co

Jun 25, 2025
pulisher
Jun 23, 2025

11 Best Most Active Stocks To Buy According to Analysts - Insider Monkey

Jun 23, 2025
pulisher
Jun 20, 2025

Cytokinetics Aligns U.S., Europe, and Japan—Could Global Synchronization Fuel Explosive Growth? - Smartkarma

Jun 20, 2025
pulisher
Jun 19, 2025

Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM - ScienceDirect.com

Jun 19, 2025
pulisher
Jun 18, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 18, 2025
pulisher
Jun 17, 2025

Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Ru - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CYTK Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Cytokinetics Awards 140,000 Shares Worth $2.9M in Employee Inducement GrantsSee Exercise Price - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

Cytokinetics CEO Robert Blum sells $169,000 in stock By Investing.com - Investing.com Canada

Jun 16, 2025
pulisher
Jun 15, 2025

Cytokinetics’ SWOT analysis: aficamten’s promise drives stock outlook By Investing.com - Investing.com India

Jun 15, 2025
pulisher
Jun 14, 2025

Cytokinetics’ SWOT analysis: aficamten’s promise drives stock outlook - Investing.com

Jun 14, 2025
pulisher
Jun 11, 2025

Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program | CYTK Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program - The Manila Times

Jun 10, 2025
pulisher
Jun 09, 2025

JP Morgan Lowers Price Target for Cytokinetics (CYTK) to $53 | CYTK Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Cytokinetics (CYTK) Target Price Cut by JPMorgan Analyst | CYTK Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

JP Morgan Lowers Price Target for Cytokinetics (CYTK) to $53 | C - GuruFocus

Jun 09, 2025
pulisher
Jun 06, 2025

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Shareholders That Lost Money on Cytokinetics, Incorporated(CYTK) Should Contact Levi & Korsinsky about Securities Fraud InvestigationCYTK - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 05, 2025

Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CY - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokinetics Inc (CYTK) - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Cytokinetics at Jefferies Conference: Aficamten’s Market Expansion By Investing.com - Investing.com Nigeria

Jun 04, 2025

Cytokinetics Inc (CYTK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
大文字化:     |  ボリューム (24 時間):